Irinotecan/Cetuximab Followed by XELOX/Cetuximab vs the Reverse Sequence in Metastatic CRC

ABSTRACT: This phase II study will evaluate which is the best way to administer cetuximab after recurrence in 1st line irinotecan+bevacizumab based treatment and to obtain results of the efficacy of the oxaliplatin+cetuximab combination as 2nd line treatment.

DISEASE(S): Colorectal Cancer,Colorectal Neoplasms

PROVIDER: 2061270 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR